Don’t forget you can visit MyAlerts to manage your alerts at any time.
Transparency rules for funders in tort mass cases, and how funding affects the "business model" of plaintiff mass tort litigaiton
By Amanda Bronstad | December 18, 2023
Kenvue, formerly Johnson & Johnson Consumer, manufacturer of Tylenol, said it planned to move for dismissal of the lawsuits after U.S. District Judge Denise Cote found all five of plaintiffs' general causation experts inadmissible.
3 minute read
By Emily Cousins | December 18, 2023
"Candidly, the court's treatment of Mr. Jones has been the biggest disappointment in my 30-year career," Norm Pattis said.
4 minute read
By Amanda Bronstad | December 18, 2023
At a Monday hearing, U.S. District Judge William Orrick, in the Northern District of California, allowed up to $150 million in attorney fees to move forward but questioned the lack of diversity among the 62 plaintiffs firms in the Juul multidistrict litigation.
5 minute read
By Aleeza Furman | December 18, 2023
The fees are slated to be paid out of the Pennsylvania Opioid Fee Fund—a chunk of money allotted for lawyers from Pennsylvania's $1.07 billion share of the $26 billion global settlement between state and local governments and Johnson & Johnson, Cardinal Health, McKesson and AmerisourceBergen.
3 minute read
By Amanda Bronstad | December 18, 2023
The U.S. Supreme Court heard oral arguments this month in the Purdue Pharma bankruptcy about third-party releases in a case that could also impact the Boy Scouts of America's Chapter 11 plan next year.
5 minute read
Delaware Business Court Insider
By Amanda Bronstad | December 18, 2023
The U.S. Supreme Court heard oral arguments this month in the Purdue Pharma bankruptcy about third-party releases in a case that could also impact the Boy Scouts of America's Chapter 11 plan next year.
5 minute read
By Law Journal Editorial Board | December 17, 2023
However 'Harrington v. Purdue Pharma' is decided, the deal leaves a bad taste.
6 minute read
By Amanda Bronstad | December 15, 2023
OptumRx, a pharmacy benefit manager facing trials over its role in the opioid crisis, has moved to disqualify Motley Rice, citing alleged ethical violations tied to confidential information the law firm received through government subpoenas.
5 minute read
By Amanda Bronstad | December 15, 2023
OptumRx, a pharmacy benefit manager facing trials over its role in the opioid crisis, has moved to disqualify Motley Rice, citing alleged ethical violations tied to confidential information the law firm received through government subpoenas.
5 minute read
By Adolfo Pesquera | December 15, 2023
A class of defendants represented by virtually every major commercial litigation law firm in Texas was granted a reversal against claims brought by consumers affected by Winter Storm Uri.
5 minute read
Presented by BigVoodoo
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS